Albireo Pharma, Inc. Banner Image

Albireo Pharma, Inc.

  • Ticker ALBO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Albireo Pharma, Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo’s lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in progressive familialMore intrahepatic cholestasis (PFIC) and biliary atresia, with a third Phase 3 trial being planned in Alagille syndrome. Albireo was spun out from AstraZeneca in 2008. Albireo Pharma is located in Boston, Mass., and its key operating subsidiary is located in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
4.8 / 5.0 (150)

Albireo Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 150 reviews.

Albireo Pharma, Inc.

Most Recent Annual Report

Albireo Pharma, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports

Albireo Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!